-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
National Osteoporosis Foundation Remembers Gregory R. Mundy, MD
WASHINGTON, D.C. (March 2, 2010) — The National Osteoporosis Foundation (NOF) mourns the passing of Gregory R. Mundy, MD, long time member of the NOF Board of Trustees. At the time of his death, Dr. Mundy was Professor of Medicine, Pharmacology, Orthopaedics and Cancer Biology at Vanderbilt University Medical Center. He was also John A. Oates Chair in Translational Medicine and Director of the Vanderbilt Center in Bone. He was formerly Professor of Cellular and Structural Biology at University of Texas Health Science Center, San Antonio, Texas and was also Assistant Dean for Clinical Research and Principal Investigator of the Frederic C. Bartter Clinical Research Unit.
Dr. Mundy served on the NOF Scientific Advisory Board and Board of Trustees from 1986 to 2008. From 1986 to 1996, he chaired the Research Grants Committee of the NOF Scientific Advisory Board. "His research was focused on early-stage drug discovery and identifying drugs which stimulate bone growth or inhibit cancer metastasis to bone," said Robert Recker, MD, NOF President. "His achievements have significantly improved the lives of many patients who have or who are at risk for osteoporosis."
Educated in Australia, he spent most of his professional career in the United States. The recipient of numerous awards for his research, he was active in several scientific societies including the American Society for Bone & Mineral Research, the International Myeloma Foundation and the International Bone & Mineral Society. In 2004, he was one of three individuals who founded the Cancer and Bone Society. In addition, he served on the editorial review board for several scientific journals.
Dr. Mundy was an internationally renowned investigator in bone biology and his research focused on osteoporosis, cancer metastasis and fracture repair. A prolific scientist, he built a record of exceptional research excellence. For more than 25 years he was in the top two percent of all National Institutes of Health grantees in terms of extramural funding. His publications numbered more than 550 original articles, reviews and book chapters, and he was an inventor on 34 issued patents. He edited two books and published two separate monographs on calcium homeostasis and bone remodeling and its disorders. Additionally, he founded two biotechnology startup companies for drug discovery for bone diseases, and two in other areas. He was a member of the Advisory Council of the National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) from1997 to 2001.
"Greg was a warm and personable guy with a great sense of humor" said Recker. "We have lost not only a great scientist but also a dear friend."
The latest
The National Osteoporosis Foundation has named Barbara Hannah Grufferman as its first Bone Health Ambassador. In this newly-established role, Grufferman, a well-known advocate for healthy and positive living, will dedicate her time, talent and energy to raise awareness for osteoporosis and the importance of building strong bones for life.
Thanks to a generous gift from The Samuel J. & Ethel LeFrak Charitable Trust, the National Osteoporosis Foundation met its Generations of Strength fundraising goal one year early. NOF launched the Generations of Strength initiative in September 2011 with the goal of raising $2 million in two years to improve patient care for the most vulnerable – those who have broken bones due to osteoporosis – and to protect future generations from the disease.
The National Osteoporosis Foundation (NOF), the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, has named Claire Gill as its Senior Director of Marketing, Consumer and Corporate Outreach. Gill brings extensive experience in public relations and marketing communications to this newly-established role.
